.Attribute Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin resulted in enhanced progression-free and general survival, bring about FDA commendation as well as a new treatment choice for individuals.